Literature DB >> 19261090

Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course.

Bong-Hee Park1, Jae Y Ro, Won Seo Park, Kowan J Jee, Kyungeun Kim, Gyungyub Gong, Yong Mee Cho.   

Abstract

Reported herein are seven cases of a histologically distinct oncocytic papillary renal cell carcinoma (OPRCC) with an inverted nuclear pattern. To define its prognostic significance, the clinicopathological features of OPRCC were compared to those of types 1 and 2 PRCC. The median age of the seven patients was 67 years. Grossly, tumors were well-circumscribed and small (1.2 cm +/- 0.4 cm). Microscopically, the OPRCC were composed of well-developed thin papillae, lined with a single layer of cuboidal-to-columnar oncocytic cells. The tumor cells had round-to-oval nuclei and eosinophilic granular cytoplasm, which was strongly positive for anti-mitochondrial immunostaining. The nuclei were characteristically polarized toward the surface of the papillae and contained mostly small nucleoli. The tumors had high expression of alpha-methylacyl-coenzyme A racemase, CD15, CD117, cytokeratin (CK) 7, E-cadherin, epithelial membrane antigen, MOC 31, mucin-1, vascular endothelial growth factor and vimentin, low expression of CD10 and Ki-67, and no expression of CK20. Genetically, gain of chromosomes 3p, 11q, and 17q, and loss of chromosome 4q was observed. All seven patients were alive with no recurrence or metastasis at a mean follow-up time of 37.1 +/- 23.7 months. In conclusion, OPRCC show unique pathological features with indolent clinical behavior and are more similar clinicopathologically to type 1 than to type 2 PRCC.

Entities:  

Mesh:

Year:  2009        PMID: 19261090     DOI: 10.1111/j.1440-1827.2009.02341.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis.

Authors:  T Urge; O Hes; J Ferda; Z Chudácek; V Eret; M Michal; M Brunelli; G Martignoni; M Hora
Journal:  World J Urol       Date:  2010-05-08       Impact factor: 4.226

2.  Small oncocytic papillary renal cell carcinoma in diabetic glomerulosclerosis.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

3.  Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.

Authors:  Qiu-Yuan Xia; Qiu Rao; Qin Shen; Shan-Shan Shi; Li Li; Biao Liu; Jin Zhang; Yan-Fen Wang; Qun-Li Shi; Jian-Dong Wang; Heng-Hui Ma; Zhen-Feng Lu; Bo Yu; Ru-Song Zhang; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 4.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

5.  Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in MSH6 and Molecular Analysis: Report of a Case and Review of the Literature.

Authors:  Yu Yang; Shweta Dhar; Jennifer Taylor; Bhuvaneswari Krishnan
Journal:  J Kidney Cancer VHL       Date:  2021-04-21

6.  Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.

Authors:  Tong Yang; Enhao Kang; Longxiao Zhang; Jie Zhuang; Yujun Li; Yanxia Jiang; Han Wang; Wenjuan Yu; Wei Zhang
Journal:  Diagn Pathol       Date:  2022-08-25       Impact factor: 3.196

7.  Oncocytic Renal Cell Carcinoma with Tubulopapillary Growth Having a Fat Component.

Authors:  Na Rae Kim; Hyun Yee Cho
Journal:  J Pathol Transl Med       Date:  2015-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.